Verruca vulgaris following treatment with tacrolimus ointment [6]

Dermatology

Volumn 213, Issue 3, 2006, Pages 254-255

  Narang, Tarun ^a   Pahwa, Manish ^a   Kanwar, Amrinder Jit ^a   Parsad, Davinder ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Tacrolimus ointment; Verruca vulgaris

Indexed keywords

TACROLIMUS;

ALOPECIA AREATA; CASE REPORT; CAUTERIZATION; CLINICAL FEATURE; DRUG EFFECT; FEMALE; HUMAN; HYPERPIGMENTATION; LETTER; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SYMPTOM; VERRUCA VULGARIS; VITILIGO;

ADMINISTRATION, TOPICAL; ALOPECIA; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; TACROLIMUS; VITILIGO; WARTS;

EID: 33750029855     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095051     Document Type: Letter

References (15)

1. Skaehill PA: Tacrolimus in dermatologic disorders. Ann Pharmacother 2001;35:582-588.
2. Hultsch T, Kapp A, Spergel J: Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005;211:174-187.
3. Brill TJ, Elshorst-Schmidt T, Valesky EM, Kaufmann R, Thaci D: Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments. Dermatology 2005;211:351-335.
4. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvares MB, Ortiz CA, Torres-Rubalcava AB: A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003;139:581-585.
5. Kanwar AJ, Dogra S, Parsad D: Topical tacrolimus for treatment of childhood vitiligo in Asians. Clin Exp Dermatol 2004;29:589-592.
6. Reitamo S, Wollenberg A, Schopf E, Perrot JL, Marks R, Ruzika T: Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000;136:999-1006.
7. Sand C: Topical tacrolimus ointment may induce skin tags in treated patients. Acta Derm Venereol 2003;83:317.
8. Bernard LA, Cunningham BB, Al-Suwaidan S, et al: A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis. Arch Dermatol 2003;139:229-231.
9. Antille C, Saurat JH, Lubbe J: Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol 2004;140:457-460.
10. Fricain JC, Sibaud V, Campana F, Lepreux S, Taïeb A: Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus. Dermatology 2005;210:229-232.
11. Siddaiah N, Erickson Q, Miller G, Elston DM: Tacrolimus-induced tinea incognito. Cutis 2004;73:237-238.
12. Ahn BK, Kim BD, Lee SJ, Lee SH: Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment. J Am Acad Dermatol 2005;52:532-533.
13. Lerbaek A, Agner T: Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus. Br J Dermatol 2004;150:1210-1211.
14. Wilson LM, Reid CM: Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment. Australas J Dermatol 2004;45:184-185.
15. Lubbe J, Pournaras CC, Saurat JH: Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment. Dermatology 2000;201:249-251.